Joanne R Chalmers

Evaluation of the measurement properties of symptom measurement instruments for atopic eczema: a systematic review

C. Terwee, A. Drucker, Å. Svensson, 2017, Allergy.

Report from the kick‐off meeting of the Cochrane Skin Group Core Outcome Set Initiative (CSG‐COUSIN)

C. Prinsen, T. Wild, M. Pinart, 2016, The British journal of dermatology.

Development and initial testing of a new instrument to measure the experience of eczema control in adults and children: Recap of atopic eczema (RECAP)†

K. Thomas, S. Lawton, P. Spuls, 2019, The British journal of dermatology.

Patient‐Oriented Eczema Measure (POEM), a core instrument to measure symptoms in clinical trials: a Harmonising Outcome Measures for Eczema (HOME) statement

H. Williams, J. Schmitt, K. Thomas, 2017, The British journal of dermatology.

A randomized controlled trial to compare the safety and effectiveness of doxycycline (200 mg daily) with oral prednisolone (0·5 mg kg−1 daily) for initial treatment of bullous pemphigoid: a protocol for the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) Trial

H. Williams, D. Bratton, D. Whitham, 2015, The British journal of dermatology.

Standardized reporting of the Eczema Area and Severity Index (EASI) and the Patient‐Oriented Eczema Measure (POEM): a recommendation by the Harmonising Outcome Measures for Eczema (HOME) Initiative

H. Williams, J. Schmitt, K. Thomas, 2018, The British journal of dermatology.